Neural Stem Cells Attack Glioblastoma Cells

Dr. Sridhar Reddy Chirasani, Professor Helmut Kettenmann and Dr. Rainer Glass (all MDC) and Dr. Michael Synowitz (Charité – Universitätsmedizin Berlin) have now shown in cell culture and mouse model experiments just how the body’s own protective mechanism they identified in an earlier study, actually works (Brain, July 6, 2010, doi:10.1093/brain/awq128)*.

Glioblastomas are brain tumors that are most common in adults in their mid-fifties or early sixties. The causes for developing the disease are not yet known. Researchers assume that misdirected neural stem cells / precursor cells mutate into cancer cells and can form glioblastomas.

Several years ago the MDC and Charité researchers were able to show that normal stem cell/ precursor cells of the brain attack the tumor. Apparently, the tumor itself entices these stem cells to migrate over relatively long distances from the stem cell niches of the brain. Why this is so is unclear. Moreover, the researchers still do not know which substance attract the stem cells to the tumor. However, now they have discovered how the stem cells keep the tumor in check.

Stem cell protein induces signaling in glioblastoma cells
The scientists showed that the neural stem cells and neural precursor cells release a protein that belongs to the family of the BMP proteins (bone morphogenetic protein). This protein received its name for its ability to induce bone and cartilage tissue formation, the first characteristic that was known about it. However, BMP is active in the entire organism – even in the brain.

Neural stem cells release BMP-7 in the brain in the vicinity of the glioblastoma cells. The protein influences a small population of cancer cells, the so-called tumor stem cells. The current consensus of researchers is that these tumor stem cells are the actual cause for the continuous tumor self-renewal in the brain. A small quantity of these cells is sufficient to form new tumors again even after surgery. BMP-7 induces signaling in the tumor stem cells, causing them to differentiate. This means that they are no longer tumor stem cells.

However, the activity of stem cells in the brain and thus of the body’s own protective mechanism against glioblastomas diminishes with increasing age. This could explain why the tumors usually develop in older adults and not in children and young people.

Aim – the destruction of tumor stem cells
The discovery of the tumor stem cells has led to new concepts in the therapy of glioblastomas. “Normal cancer cells” can be destroyed using conventional therapies (surgery, radiation, chemotherapy), which are seldom successful in tumor stem cells. The aim is therefore to develop therapy concepts to destroy these tumor stem cells. The findings from the mouse experiments of the researchers in Berlin could point to a new approach: reprogramming tumor stem cells into less harmful cells, which could then be destroyed with a therapy.
* Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells
Sridhar Reddy Chirasani,1 Alexander Sternjak,2 Peter Wend,3 Stefan Momma,4 Benito Campos,5 Ilaria M. Herrmann,5 Daniel Graf,6 Thimios Mitsiadis,6 Christel Herold-Mende,5 Daniel Besser,7 Michael Synowitz,1,8 Helmut Kettenmann1,* and Rainer Glass1,*
1 Cellular Neuroscience Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany
2 Cellular Immunology Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany
3 Signal Transduction, Epithelial Differentiation, and Invasion and Metastasis Groups, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany
4 Restorative Neurology Group, Edinger Institute Frankfurt/M., 60528 Frankfurt/M., Germany
5 Division of Neurosurgical Research, Department of Neurosurgery, University of Heidelberg, 69120 Heidelberg, Germany
6 Institute of Oral Biology, ZZMK, Medical Faculty, University of Zurich, 8032 Zürich, Switzerland
7 Embryonic Stem Cells-Research Group, Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany
8 Department of Neurosurgery, Charite´ University Hospital, 13353 Berlin, Germany

*These authors contributed equally to this work.

Barbara Bachtler
Press and Public Affairs
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Straße 10; 13125 Berlin; Germany
Phone: +49 (0) 30 94 06 – 38 96
Fax: +49 (0) 30 94 06 – 38 33
e-mail: presse@mdc-berlin.de

Media Contact

Barbara Bachtler Max-Delbrück-Centrum

More Information:

http://www.mdc-berlin.de/

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors